IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
According to IM Cannabis Corp.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.73. At the end of 2022 the company had a P/E ratio of -2.25.
Year | P/E ratio |
---|---|
2023 | -3.73 |
2022 | -2.25 |
2021 | -6.18 |
2020 | -81.82 |
2019 | -35.17 |
2018 | 20.09 |
2017 | -5.18 |
2016 | -39.35 |
2015 | -13.59 |
2014 | -82.23 |
2013 | -14.09 |
2012 | -2.90 |
2011 | -117.43 |
2010 | -161.24 |
2009 | -57.08 |
2008 | -53.43 |
2007 | -69.69 |
2006 | -61.77 |
2005 | -26.44 |
2004 | -2486.33 |
2003 | -22.80 |
2002 | -27.47 |
2001 | -38.08 |
2000 | -12.38 |
1999 | -37.50 |
1998 | -11.14 |
1997 | -21.82 |
1996 | -95.00 |